CIK: 0001799883 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 3, 2022
Total Value ($000): $532,794 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | PEAR THERAPEUTICS INC | 18,631,771 | $115,517 | 21.7% | $6.20 | — | CLASS A COM | 704723105 |
| TRDA | ENTRADA THERAPEUTICS INC | 4,408,379 | $75,471 | 14.2% | $17.12 | — | COM | 29384C108 |
| — | VOR BIOPHARMA INC | 6,361,723 | $73,923 | 13.9% | $43.10 | — | COM | 929033108 |
| — | RALLYBIO CORP | 4,190,724 | $39,980 | 7.5% | $17.58 | — | COM | 75120L100 |
| — | AKOUOS INC | 4,135,784 | $35,154 | 6.6% | $22.50 | — | COM | 00973J101 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,398,066 | $33,050 | 6.2% | $7.13 | +225.6% | COM | 45166A102 |
| ARVN | ARVINAS INC | 400,000 | $32,856 | 6.2% | $29.28 | +178.0% | COM | 04335A105 |
| — | IMPEL NEUROPHARMA INC | 2,884,791 | $24,896 | 4.7% | $8.85 | — | COM | 45258K109 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 862,286 | $24,498 | 4.6% | $19.04 | +29.5% | COM | 22663K107 |
| — | SCPHARMACEUTICALS INC | 3,831,474 | $19,234 | 3.6% | $5.92 | — | COM | 810648105 |
| — | HOMOLOGY MEDICINES INC | 4,535,919 | $16,511 | 3.1% | $20.70 | — | COM | 438083107 |
| — | IVERIC BIO INC | 643,248 | $10,755 | 2.0% | $16.24 | — | COM | 46583P102 |
| RNAM | AVIDITY BIOSCIENCES INC | 390,555 | $9,283 | 1.7% | $21.74 | +9.9% | COM | 05370A108 |
| JANX | JANUX THERAPEUTICS INC | 446,266 | $8,805 | 1.7% | $22.27 | -5.9% | COM | 47103J105 |
| CABA | CABALETTA BIO INC | 2,064,263 | $7,824 | 1.5% | $11.85 | -10.0% | COM | 12674W109 |
| — | 5 01 ACQUISITION CORP | 365,126 | $3,596 | 0.7% | $10.17 | — | COM CL A | 33836P105 |
| — | CIDARA THERAPEUTICS INC | 1,134,511 | $1,441 | 0.3% | $3.84 | — | COM | 171757107 |